Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 2500.00 | 1344.63 | 3856.00 | 3809.50 | 1.0122 | 1.0162 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 3551.00 | 3809.50 | 0.9321 | 0.9086 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 2500.00 | 1344.63 | 3524.00 | 3809.50 | 0.9251 | 0.8989 |
| BT-20 | Lapatinib | 1 | uM | 8 | 2500.00 | 1344.63 | 3511.00 | 3809.50 | 0.9216 | 0.8943 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3500.00 | 3809.50 | 0.9188 | 0.8903 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 2945.00 | 3809.50 | 0.7731 | 0.6851 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 5961.00 | 7143.75 | 0.8344 | 0.8646 | |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 6662.00 | 7143.75 | 0.9326 | 0.9466 | |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 5000.00 | 1193.65 | 6563.00 | 7143.75 | 0.9187 | 0.9354 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 5000.00 | 1193.65 | 5042.00 | 7143.75 | 0.7058 | 0.7475 |
| BT-20 | Linsitinib | 10 | uM | 8 | 5000.00 | 1193.65 | 5532.00 | 7143.75 | 0.7744 | 0.8114 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 5000.00 | 1193.65 | 6536.00 | 7143.75 | 0.9149 | 0.9323 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 5000.00 | 1193.65 | 3932.00 | 7143.75 | 0.5504 | 0.5870 |
| BT-20 | Erlotinib | 1 | uM | 8 | 5000.00 | 1193.65 | 5715.00 | 7143.75 | 0.8000 | 0.8344 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 5000.00 | 1193.65 | 7030.00 | 7143.75 | 0.9841 | 0.9876 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7255.00 | 7143.75 | 1.0156 | 1.0120 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 5000.00 | 1193.65 | 6762.00 | 7143.75 | 0.9466 | 0.9579 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 5000.00 | 1193.65 | 6998.00 | 7143.75 | 0.9796 | 0.9841 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 5000.00 | 1193.65 | 7081.00 | 7143.75 | 0.9912 | 0.9932 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 5000.00 | 1193.65 | 7112.00 | 7143.75 | 0.9956 | 0.9966 |
| BT-20 | 0 | uM | 8 | 5000.00 | 1193.65 | 7081.00 | 7143.75 | 0.9912 | 0.9932 | |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 5000.00 | 1193.65 | 7165.00 | 7143.75 | 1.0030 | 1.0023 |
| BT-20 | Erlotinib | 10 | uM | 8 | 5000.00 | 1193.65 | 4690.00 | 7143.75 | 0.6565 | 0.6992 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 5000.00 | 1193.65 | 7246.00 | 7143.75 | 1.0143 | 1.0110 |
| BT-20 | Lapatinib | 10 | uM | 8 | 5000.00 | 1193.65 | 3623.00 | 7143.75 | 0.5072 | 0.5375 |